UEG-26320-46531 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-07-27
Dose 1 — Pfizer-BioNTech
2021-08-17
Registered in v-safe
2021-08-17
Dose 2 — Pfizer-BioNTech
2021-08-17
Health check-in — day 0, dose 2
Feeling: Good · Muscle or body aches

Adult check-in
2021-08-18
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school

Adult check-in
2021-08-19
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Swelling · None

Adult check-in
2021-09-11
Survey response — day 21, dose 2
MedDRA: Headache, Nasal discomfort — Feeling: Fair · Be unable to do your normal daily activities

Free text: Nose is burning and I have a headache

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-07-27	Pfizer-BioNTech	No
2	2021-08-17	Pfizer-BioNTech	No

Free text

Release 9 — day 21, dose 2

2021-09-11

Symptoms: Nose is burning and I have a headache

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Headache	·	·	✓
SD	Nasal discomfort	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release